(S)-3-苯基-2-氨基丙硫醇盐酸盐的合成

以L 苯丙氨酸为原料经还原反应得到氨基醇,用Boc基团进行氨基保护后得到(S) 3 苯基 2 叔丁氧羰基氨基 1 丙醇,甲磺酰化后与硫代乙酸钾在DMF中反应得到(S) 3 苯基 2 叔丁氧羰基氨基 1 丙硫醇乙酸酯,再分别脱除乙酰基,氨基保护基后得到(S) 3 苯基 2 氨基丙硫醇盐酸盐.并用元素分析、红外光谱、核磁共振等手段对中间体和目标化合物进行了表征.     

Chiral separation of trimetoquinol hydrochloride and related compounds by micellar electrokinetic chromatography using sodium taurodeoxycholate solutions and application to optical purity determination

The chiral separation of trimetoquinol hydrochloride, which is a bronchodilator (Inolin), and three related compounds by micellar electrokinetic chromatography was investigated using a bile salt as a chiral surfactant. Enantiomers of these compounds, except laudanosoline, were successfully separated within 12 min using a separation tube of effective length 500 mm × 0.05 rum i.d. and a 0.05 M sodium taurodeoxycholate solution of pH 7.0. The observed theoretical plate numbers of the peaks were ca. 150000. Chiral recognition was affected by the structure of bile salts, the pH of the buffer solutions used and the structure of the solutes. Of four kinds of bile salts, successful chiral separation was achieved only using sodium taurodeoxycholate solution under neutral conditions. The method was applied to the optical purity determination of trimetoquinol hydrochloride. The effects of surfactant concentrations and some additives to the micellar solution are briefly described.     

Complexometric determination of thallium(III) in pure solution,alloys, and complexes using semicarbazide hydrochloride as a releasing agent

A simple and accurate complexometric method is proposed for the determination of Tl(III) using semicarbazide hydrochloride as a releasing agent. In the presence of diverse metal ions, thallium is complexed first with a known excess of EDTA, and the surplus EDTA is then titrated with standard zinc sulfate at pH 5.0–6.0 (hexamine) using xylenol orange indicator. An excess of 5% aqueous neutral solution of semicarbazide hydrochloride is then added and the released EDTA is titrated against standard zinc sulfate solution. The method works well in the range 2–50 mg of Tl(III) with relative errors < 0.5%, standard deviations 0.05mg and coefficient of variation 0.4%. The method is applied for the determination of thallium content in complexes and alloy compositions     

盐酸环丙沙星的合成

以３－氯－４－氟苯胺为起始原料，经六步反应合成盐酸环丙沙星，总收率达４２．３％，高于现有文献报道值。经元素分析，红外光谱和核磁共振谱确认了产物的结构。     

The electrochemistry and determination of Ligustrazine hydrochloride

Ligustrazine is one of the active ingredients contained in Ligusticum chuanxiong Hort. (Umbelliferae), which is widely used in traditional Chinese medicine for the treatment of cardiovascular problems. In this work, the electrochemistry of Ligustrazine hydrochloride (LZC) and its determination are investigated. The detection limit is estimated to be 8.0×10^–8 M, with three linear ranges from 1.0×10^–6 to 1.0×10^–4 M, 1.0×10^–4 to 5.0×10^–4 M, and 6.5×10^–4 to 1.6×10^–3 M. The method has been proved to be highly sensitive, selective, and stable, and has been successfully applied to determining LZC in LZC injections.     

阿拉伯糖基有序介孔碳修饰电极检测盐酸奈福泮的研究

以阿拉伯糖为碳源,介孔硅(SBA-15)为模板剂,用硬模板法制备有序介孔碳材料,采用场发射扫描电镜(Scanning Electron Microscopy,SEM)、透射电子显微镜(Transmission Electron Microscope,TEM)、全自动比表面及孔隙度分析仪(Brunner Emmet Te...     

氮氧自由基电催化氧化盐酸伪麻黄碱的电化学行为及其电化学动力学性质

运用循环伏安法(CV)、计时电流法(CA)在玻碳电极(GCE)上研究了以氮氧自由基(4-羟基-2,2,6,6-四甲基-哌啶-1-氧自由基,TEMPOL)为均相电子转移媒体电催化氧化盐酸伪麻黄碱(PEH)的电化学行为及其电化学动力学性质.研究结果表明,PEH在GCE上的电化学氧化过程十分迟缓,不易直接发生电化学氧化反应.而在TEMPOL存在时PEH在0.641 V处出现了一个不可逆的氧化峰,且峰电流大幅度增加,表明TEMPOL对PEH的电化学氧化具有良好的电催化作用.在5～1 000 mV/s扫描速度范围内,氧化峰电流(Ipa)与扫描速率平方根(v1/2)呈线性关系,此催化氧化反应是一受扩散控制的电极过程.测定了电催化氧化反应动力学参数:电子转移系数α为0.72,催化反应速率常数k为(2.26±0.05)×103(mol/L)/s.催化体系氧化峰电流与PEH浓度在2.0×10-5～2.0×10-3mol/L范围内呈良好的线性关系,检出限为1.0×10-5mol/L.     

Flow Injection Chemiluminescence Method for Nalbuphine Hydrochloride in Pharmaceutical Formulations Using Tris(2,2'-bipyridyl)ruthenium(II) Chloride-diperiodatocuprate(III) Reaction

Asensitive and selective method employing chemiluminescence(CL) coupled with flow injection(FI) is reported for nalbuphine hydrochloride(NAL) assay in pharmaceutical formulations. The enhancement effect of NAL on the CL reaction between tris(2,2'-bipyridyl)ruthenium(II) chloride-diperiodatocuprate(III) {Ru[(bpy)₃]²⁺-Cu(III) complex} in acidic medium is used as analytical measurement. The optimal conditions of the CL reaction were sulfuric acid 1.0×10^-3 mol/L, Ru[(bpy)₃]²⁺ 7.5×10^-5 mol/L, Cu(III)/Ag(III) complexes 4.0×10^-4/5.0×10^-4 mol/L, sample loop volume of 120 μL and flow rate of 2.5 mL/min. The sensitivities of the method in terms of detection(S/N=3) and quantification(S/N=10) limits are 5×10^-4 and 0.001 ppm(1 ppm=1 mg/L), respectively. The linear response of the instrument in the form of CL intensity with respect to NAL concentration is over the range 0.001-15.0 ppm(R²=0.9999) with relative standard deviation from 0.8% to 3.2% and injection throughput of 120 injection/h. The applications of the method include the quantitative analysis of NAL in pharmaceutical injection samples. Variations and the average results of the proposed method are not signi-ficantly different from the results of a reported method by applying F- and paired student t-test. The most likely CL reaction mechanism is written in accordance with spectrophotometric and CL studies.     

Preparation of Co-Processed Excipients for Controlled-Release of Drugs Assembled with Solid Lipid Nanoparticles and Direct Compression Materials

The purpose of the study was to develop a novel, directly compressible, co-processed excipient capable of providing a controlled-release drug system for the pharmaceutical industry. A co-processed powder was formed by adsorption of solid lipid nanoparticles (SLN) as a controlled-release film onto a functional excipient, in this case, dicalcium phosphate dihydrate (DPD), for direct compression (Di-Tab^®). The co-processed excipient has advantages: easy to implement; solvent-free; industrial scaling-up; good rheological and compressibility properties; and the capability to form an inert platform. Six different batches of Di-Tab^®:SLN weight ratios were prepared (4:0.6, 3:0.6, 2:0.6, 1:0.6, 0.5:0.6, and 0.25:0.6). BCS class III ranitidine hydrochloride was selected as a drug model to evaluate the mixture’s controlled-release capabilities. The co-processed excipients were characterized in terms of powder rheology and dissolution rate. The best Di-Tab^®:SLN ratio proved to be 2:0.6, as it showed high functionality with good flow and compressibility properties (Carr Index = 16 ± 1, Hausner Index = 1.19 ± 0.04). This ratio could control release for up to 8 h, so it fits the ideal profile calculated based on biopharmaceutical data. The compressed systems obtained using this powder mixture behave as a matrix platform in which Fickian diffusion governs the release. The Higuchi model can explain their behavior.     

Infrared and Raman Study of Benzocaine Hydrochloride

The infrared and laser Raman spectra (100-4000 cm¹) of benzocaine hydrochloride were recorded and its vibrations analysed. A theoretical spectrum with the AM1 semiempirical method was calculated. An infrared study with the temperature was also made. From the experimental data, the torsion and inversion barriers of amine group were calculated.